These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36375704)

  • 21. Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
    Kini AS; Motoyama S; Vengrenyuk Y; Feig JE; Pena J; Baber U; Bhat AM; Moreno P; Kovacic JC; Narula J; Sharma SK
    JACC Cardiovasc Interv; 2015 Jun; 8(7):937-45. PubMed ID: 26088511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
    Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X; Tamez H; Lai C; Ho K; Cutlip D
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
    Moussa ID; Klein LW; Shah B; Mehran R; Mack MJ; Brilakis ES; Reilly JP; Zoghbi G; Holper E; Stone GW;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):27-36. PubMed ID: 23894025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
    J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periprocedural myocardial infarction during percutaneous coronary intervention in an academic tertiary centre in Johannesburg.
    Tsabedze N; McCutcheon K; Mkhwanazi L; Garda R; Vachiat A; Ramjee R; Moosa J; Maluleke T; Mukeshimana G; Karolia S; Mpanya D; Manga P
    Int J Cardiol; 2017 Mar; 230():175-180. PubMed ID: 28062147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
    Leonardi S; Lopes RD; Steg PG; Abnousi F; Menozzi A; Prats J; Mangum S; Wilson M; Todd M; Stone GW; Gibson CM; Hamm CW; Price MJ; White HD; Harrington RA; Bhatt DL; Mahaffey KW
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):158-165. PubMed ID: 27485140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI.
    Piccolo R; Leone A; Avvedimento M; Simonetti F; Ippolito D; Angellotti D; Verde N; Manzi L; Cirillo P; Serafino LD; Fortunato G; Franzone A; Esposito G
    Eur Heart J Qual Care Clin Outcomes; 2023 Nov; 9(7):680-690. PubMed ID: 36385164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microcirculatory significance of periprocedural myocardial necrosis after percutaneous coronary intervention assessed by the index of microcirculatory resistance.
    Wu Z; Ye F; You W; Zhang J; Xie D; Chen S
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):995-1002. PubMed ID: 24816909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
    Fanaroff AC; Kaltenbach LA; Peterson ED; Hess CN; Cohen DJ; Fonarow GC; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.